Anthony J Sampognaro

Title: The Innovative Contributions of Anthony J Sampognaro

Introduction

Anthony J Sampognaro is a notable inventor based in Meriden, Connecticut. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential applications in cancer treatment and Alzheimer's disease.

Latest Patents

Sampognaro holds two patents that highlight his innovative work. The first patent is for "Substituted imidazoles as casein kinase 1 D/E inhibitors." This invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity, making them useful as anticancer agents. The second patent is for "Pyrrolotriazine kinase inhibitors." This invention also provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity, which makes them useful as anti-cancer agents and for the treatment of Alzheimer's Disease.

Career Highlights

Sampognaro is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at this esteemed organization has allowed him to focus on innovative drug development and contribute to advancements in medical science.

Collaborations

Throughout his career, Sampognaro has collaborated with talented individuals such as Mark D Wittman and Upender Velaparthi. These collaborations have fostered a creative environment that encourages the development of groundbreaking solutions in the pharmaceutical industry.

Conclusion

Anthony J Sampognaro's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his commitment to innovation and improving healthcare. His work continues to have a significant impact on the development of treatments for serious diseases.